Psychological and Psychiatric Consequences of Cocaine

  • M. Elena Denison
  • Alfonso Paredes
  • Shana Bacal
  • Frank H. Gawin


Systematic observations of abuse and abstinence patterns that refine conceptualizations of street cocaine abuse and dependence are rare and, unfortunately, practical and ethical design restrictions on systematic inpatient research render clinical generalization from such studies negligible. Thus, a significant proportion of the clinical research base and clinical consensus is gleaned from experiences with heterogeneous “street” samples.


Cocaine Abuse Cocaine User Cocaine Dependence Chronic Cocaine Psychiatric Consequence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alper, K. R., Chabot, R. J., Kim, A. H., Prichep, L., and John, E. (1990). Quantitative EEG correlates of crack cocaine dependence. Psychiatry Research, 35, 95–105.PubMedCrossRefGoogle Scholar
  2. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders ( 3rd ed. ). Washington, DC: Author.Google Scholar
  3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders ( 4th ed. ). Washington, DC: Author.Google Scholar
  4. Ball, J. C. (1994). Why has it proved so difficult to match drug abuse patients to appropriate treatment? Addiction, 89, 263–265.PubMedCrossRefGoogle Scholar
  5. Banerjee, S. P, Sharma, V. K., Kung-Cheung, L. S., Chanda, S. K., and Riggi, S. J. (1979). Cocaine and D-amphetamine induce changes in central betaadrenoceptor sensitivity: Effects of acute and chronic drug treatment. Brain Research, 175, 199–239.CrossRefGoogle Scholar
  6. Biederman, J., Wilens, T., Milberger, S., Spencer, T. J., and Faraone, S. V. (1995). Psychoactive substance abuse disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652–1658.PubMedGoogle Scholar
  7. Blum, K., and Noble, E. (1990). Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association, 263, 2055–2060.PubMedCrossRefGoogle Scholar
  8. Borison, R. L., Hitri, A., Klawans, H. L., and Diamond, B. I. (1979). A new animal model for schizophrenia: Behavioral and receptor binding studies. In E. Usdin, G. Kopin, and J. Barchas (Eds.), Catecholamine: Basic and clinical frontiers (pp. 719–721 ). New York: Pergamon.Google Scholar
  9. Bowers, M. B., lmirowicz, R., Druss, B., and Mazure, C. M. (1995). Autonomous psychosis following psychotogenic substance abuse. Biological Psychiatry, 37, 136–137.PubMedCrossRefGoogle Scholar
  10. Boyd, C. J. (1993). The antecedents of women’s crack cocaine abuse: Family substance abuse, sexual abuse, depression and illicit drug use. Journal of Substance Abuse Treatment, 10, 433–438.PubMedCrossRefGoogle Scholar
  11. Brody, S. L., Slovis, C. M., and Wrenn, K. D. (1990). Cocaine related medical problems: Consecutive series of 233 patients. American Journal of Medicine, 88, 325–331.PubMedCrossRefGoogle Scholar
  12. Carroll, K. M., and Rounsaville, B. J. (1993). History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 3475–82.Google Scholar
  13. Carroll, K. M., Ball, S. A., Barbor, T. F., and Rounsaville, B. J. (1995). Subtypes of cocaine abusers: Support for a type A-type B distinction. Journal of Consulting and Clinical Psychology 63115–124.Google Scholar
  14. Colpaert, E C., Niemegeers, C. H., and Janssen, P. A. (1979). Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacology, Biochemistry and Behavior, 10, 535546.Google Scholar
  15. Connell, P. H. (1969). Some observations concerning amphetamine misuse: Its diagnosis, management, and treatment with special reference to research needs, drugs and agement, and treatment with special reference to research needs. In J. R. Wittenborn, H. Brill, J. P. Smith, and S. A. Wittenborn (Eds.), Drugs and youth (pp. 125–134 ). Springfield, IL: Thomas.Google Scholar
  16. Cowley, D. S. (1992). Alcohol abuse, substance abuse, and panic disorder. American Journal of Medicine, 92, 41S - 48S.PubMedCrossRefGoogle Scholar
  17. Denison, M. E., Engelhardt, R., Jekel, J., and Gawin, E (in press).Cocaine withdrawal.Google Scholar
  18. Ellinwood, E. H., and Petrie, W. M. (1977). Dependence on amphetamine, cocaine and other stimulants. In S. N. Pradhan (Ed.), Drug abuse: Clinical and basic aspects (pp. 249–262 ). New York: Mosby.Google Scholar
  19. Fitzgerald, J. 1., and Reid, J. J. (1991). Chronic cocaine treatment does not alter rat striatal D2 autoreceptor sensitivity to pergolide. Brain Research, 541, 327–333.PubMedGoogle Scholar
  20. Flynn, P. M., Luckey, J. W., Brown, B. S., Hoffman, J. A., Dunteman, G. H., Thiesen, A. C., Hubbard, R. L., Needle, R., Schneider, S. J., and Koman, J. J., 3d. (1995). Relationship between drug preference and indicators of psychiatric impairment. American Journal of Drug and Alcohol Abuse, 21, 153–166.CrossRefGoogle Scholar
  21. Gawin, E H. (1978). Drugs and Eros: Reflections on aphrodisiacs. Journal of Psychoactive Drugs, 10, 227–236.CrossRefGoogle Scholar
  22. Gawin, E H. (1991). Cocaine addiction: Psychology and neurophysiology [published erratum appears in Science, Aug. 2, 253–494, 1991]. Science, 251, 1580–1586.Google Scholar
  23. Gawin, E H., and Ellinwood, E. H. (1988). Stimulants: Actions, abuse, and treatment. New England Journal of Medicine, 318, 1173–1183.Google Scholar
  24. Gawin, E H., and Ellinwood, E. H. (1990). Consequences and correlates of cocaine abuse: Clinical phenomenology. In N. D. Volkow and A. C. Swan (Eds.), Cocaine and the brain (pp. 155–178 ). New Brunswick, NJ: Rutgers University Press.Google Scholar
  25. Gawin, E H., and Kleber, H. D. (1984). Cocaine abuse treatment: An open trial with lithium and desipramine. Archives of General Psychiatry, 41, 903–910.Google Scholar
  26. Gawin, E H., and Kleber, H. D. (1985a). Cocaine abuse in a treatment population: Patterns and diagnostic distractions. In E. H. Adams and N. J. Kozel (Eds.), Cocaine use in America: Epidemiologie and clinical perspectives (NIDA Research Monograph No. 61, pp. 182–192 ). Rockville, MD: U.S. Department of Health and Human Services.Google Scholar
  27. Gawin, E H., and Kleber, H. D. (1985b). Cocaine use in a treatment population: Patterns and diagnostic distinctions (NIDA Research Monograph No. 61, pp. I82–192 ). Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office.Google Scholar
  28. Gawin, F. H., and Kleber, H. D. (1986). Cocaine abuse: Abstinence symptomatoloty and psychiatric diagnosis. Archives of General Psychiatry, 43, 107–113.PubMedCrossRefGoogle Scholar
  29. Gawin, E H., Khalsa, M. E., and Anglin, M. D. (1992). Subjective symptoms of cocaine withdrawal (NIH Publication No. 92–1888, p. 442). Washington, DC: U.S. Department of Health and Human Services.Google Scholar
  30. Gay, G. R. (1982). Clinical management of acute and toxic cocaine poisoning. Annals of Emergency Medicine, //, 562–572.Google Scholar
  31. Gelernter, J., Goldman, D., and Risch, N. (1993). The Al allele, at the D2 dopamine receptor gene and alcoholism: A reappraisal. Journal of the American Medical Association, 269, 1801–1807.CrossRefGoogle Scholar
  32. Hagan, T. (1988). A retrospective search for the etiology of drug abuse: A background comparison of a drug-addicted population of women and a control group of non-addicted women (NIDA Research Monograph No. 81, pp. 254–261). Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office.Google Scholar
  33. Handelsman, L., Branchey, M. H., Buydens-Branchey, L., Gribomont, B., Holloway, K., and Silverman, J. (1993). Morbidity risks for alcoholism and drug abuse in relatives of cocaine addicts. American Journal of Drug and Alcohol Abuse, /9, 347–357.Google Scholar
  34. Henry, D. J., and White, E J. (1991). Repeated cocaine administration causes persistent enhancement of DI dopamine receptor sensitivity within the rat nucleus accumbens. Journal of Pharmacology and Experimental Therapeutics, 258, 882–890.PubMedGoogle Scholar
  35. Holden, C. (1994). A cautionary genetic tale: The sobering story of D2. Science, 264, 1696–1697.PubMedCrossRefGoogle Scholar
  36. Hollander, E., Nunes, E., Decaria, C. M., Quitkin, E, Cooper, T., Wager, S., and Klein, D. (1990). Dopaminergic sensitivity and cocaine abuse: Response to apomorphine. Psychiatry Research, 33, 161–169.PubMedCrossRefGoogle Scholar
  37. Horgan, J. (1992). D2 or not D2. A barroom brawl over an alcoholism gene. Scientific American, 266, 29–32.PubMedCrossRefGoogle Scholar
  38. Karoum, E, Suddath, R. I., and Wyatt, R. J. (1990). Chronic cocaine and rat brain catecholamines: Long term reduction in hypothalamic and frontal cortex dopamine metabolism. European Journal of Pharmacology. 1861–8.Google Scholar
  39. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroine and cocaine de- pendence. American Journal of Psychiatry, 142, 1259–1264.PubMedGoogle Scholar
  40. Kidd, K. (1993). Associations of disease with genetic markers: Deja vu all over again. American Journal of Medical Genetics, 48, 71.PubMedCrossRefGoogle Scholar
  41. Kleber, H. D., and Gawin, F. H. (1984). Cocaine abuse: A review of current experimental treatments. In J. Grabowski (Ed.), Cocaine pharmacology, effects, and treatment of abuse (NIDA Research Monograph No. 50, DHHS Publication No. 84–1326 ). Rockville, MD: U.S. Department of Heath and Human Services.Google Scholar
  42. Kokkinidis, L., Zacharko, R. M., and Predy, P. A. (1980). Post-amphetamine depression of self-stimulation responding from substantia nigra: Reversal by tricyclic anti-depressants. Pharmacology, Biochemistry and Behavior, /3, 379–383.Google Scholar
  43. Kosten, T. A., Kosten, T. R., and Rounsaville, B. J. (1991). Cocaine symptoms are predicted by familial psychopathology (NIDA Research Monograph No. 105, pp. 603–604 ). Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office.Google Scholar
  44. Kramer, J. C., Fischman, V. S., and Littlefield, D. C. (1967). Amphetamine abuse patterns and effects of high doses taken intravenously. Journal of the American Medical Association, 201, 305–309.PubMedCrossRefGoogle Scholar
  45. Lasagna, L., Von Flesinger, J. M., and Beecher, H. K. (1955). Drug induced mood changes in man: I. Observations on healthy subjects, chronically ill patients, and post-addicts. Journal of the American Medical Association, /57, 1066–1020.Google Scholar
  46. Lee, M. A., Bowers, M. M., Nach, J. F., and Meltzer, H. (1990). Neuroendocrine measures of dopaminergic function in chronic cocaine users. Psychiatry Research, 33, 151–159.Google Scholar
  47. Leith, N. J., and Barrett, R. J. (1976). Amphetamine and the reward system: Evidence for tolerance and post-drug depression. Psychopharmacology (Berlin) 74, 23–28.Google Scholar
  48. Lesswing, N. J., and Dougherty, R. J. (1993). Psychopathology in alcohol and cocaine-dependent patients: A comparison of findings from psychological testing. Journal of Substance Abuse Treatment, 10, 53–57.PubMedCrossRefGoogle Scholar
  49. Lewin, L. (1924). Phantastica. Berlin: Verlag Von Georg Stilke.Google Scholar
  50. Maier, H. W. (1926). Der Kokainismus. Leipzig, Germany: Georg Thieme Verlag.Google Scholar
  51. Margolin, A., Avants, S. K., and Kosten, T. R. (1996). Abstinence symptomatology associated with cessation of chronic cocaine abuse among methadone-maintained patients. American Journal of Drug and Alcohol Abuse, 22, 377–388.PubMedCrossRefGoogle Scholar
  52. Markou, A., and Koob, G. F. (1991). Post cocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology, 4, 17–26.PubMedGoogle Scholar
  53. McCaul, M. E., Turkkan, J. S., Svikis, D. S., and Bigelow, G. E. (1990). Alcohol and secobarbital effects as a function of familial alcoholism: Acute psychophysio- logical effects. Alcoholism, Clinical and Experimental Research, 14. 704–712.CrossRefGoogle Scholar
  54. Miller, N. S.. Gold, M. S., Belkin, B. H., and Klahr, A. L. (1989). Family history and diagnosis of alcohol dependence in cocaine dependence. Psychiatry Research, 29, 113–121.Google Scholar
  55. Mirin, S. M., Weiss, R. D., Griffin, M. L., and Michael, J. L. (1991). Psychopathology in drug abusers and their families. Comprehensive Psychiatry, 32, 36–51.PubMedCrossRefGoogle Scholar
  56. Mitchell, J., and Vierkant, A. D. (1991). Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: A comparative study. Journal of Psychology, 125, 301–310.PubMedCrossRefGoogle Scholar
  57. National Institute on Drug Abuse. (1986). NIDA capsules: 1985 National Household Survey on Drug Abuse. Rockville, MD: Press Office of the National Institute on Drug Abuse.Google Scholar
  58. Noble, E., Blum, K., Khalsa, M. E., Ritchie, T., Montgomery, A., Wood, R., Fitch, R., Ozkaragoz, T., Sheridan, P., and Anglin, M. (1993). Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug and Alcohol Dependence, 33, 271–285.PubMedCrossRefGoogle Scholar
  59. Nunes, E. V, McGrath, P J., Quitkin, E M., OcepekWelikson, K., Stewart, J., Koenig, T., Wager, S., and Klein, D. (1995). Imipramine treatment of cocaine abuse: Possible boundaries of efficacy. Drug and Alcohol Dependence, 39, 185–195.PubMedCrossRefGoogle Scholar
  60. Ricaurte, G. A., Schuster, C. R., and Seiden, L. S. (1980). Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Research, 193. 153–163.PubMedCrossRefGoogle Scholar
  61. Robertson, M. W., Leslie, C. A., and Bennett, J. P. (1991). Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Research, 538, 337–339.PubMedCrossRefGoogle Scholar
  62. Rosen, M. 1., and Kosten, T. (1992). Cocaine-associated panic attacks in methadone-maintained patients. American Journal of Drug and Alcohol Abuse. 18, 57–62.CrossRefGoogle Scholar
  63. Satel, S. L., Price, L. H.. Palumbo, J. M., McDougle, C. J.. Krystal, J. H., Gawin, F. H., Charney, D. S.. Heninger, G. R., and Kleber, H. D. (1991). Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study. American Journal of Psychiatry, 148, 1712–1716.PubMedGoogle Scholar
  64. Satel, S. L., Southwick, S. M., and Gawin, E H. (1991). Clinical features of cocaine-induced paranoia. American Journal of Psychiatry, 148, 495–498.PubMedGoogle Scholar
  65. Siegel, R. K. (1982). Cocaine free base abuse: A new smoking disorder. Journal of Psychoactive Drugs, 14, 321–338.CrossRefGoogle Scholar
  66. Siegel, R. K. (1985). New patterns of cocaine use: Changing doses and routes. In E. H. Adams and N. J. Kozel (Eds.), Cocaine use in America: Epidemiologie and clinical perspectives (NIDA Research Monograph No. 61, pp. 204–220 ). Rockville, MD: U.S. Department of Health and Human Services.Google Scholar
  67. Simpson, D. M., and Arnau, Z. (1977). Behavioral withdrawal following several psychoactive drugs. Biochemistry and Behavio,; 7, 59–64.CrossRefGoogle Scholar
  68. Smith, J. W, and Frawley, P. J. (1992). Alcoholism in relatives of primary cocaine-dependent patients. Journal of Substance Abuse Treatment, 9, 153–155.PubMedCrossRefGoogle Scholar
  69. Taylor, D. L., Ho, B. T., and Fagan, J. D. (1979). Increased dopamine receptor binding in rat brain by repeated cocaine injection. Community Psychopharmacology, 3, 137–142.Google Scholar
  70. Utena, H. (1966). Behavioral aberrations in methamphetamine intoxicated animals and chemical correlates in the brain. Progress in Brain Research, 2, 192–207.CrossRefGoogle Scholar
  71. Van Dyke, C., Ungerer, J., Jatlow, P., Barash, P., and Byck, R. (1982). Intranasal cocaine dose relationships of psychological effects and plasma levels. International Journal of Psychiatry in Medicine, 12, 1–13.PubMedCrossRefGoogle Scholar
  72. Volkow, N. D., Mullani, N., Gould, K., Adler, S., and Krajewski, K. (1988). Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. British Journal of Psychiatry, 152, 641–648.PubMedCrossRefGoogle Scholar
  73. Ward, M. E, Wender, P. H., and Reimherr, F. W. (1993). The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry, /50, 885–890.Google Scholar
  74. Watson, R., Hartmann, E., and Schildkraut, J. J. (1972). Amphetamine withdrawal: Affective state, sleep patterns and MHPG excretion. American Journal of Psychiatry, 129, 263–269.PubMedGoogle Scholar
  75. Watson, R., Bakos, L., Compton, P., and Gawin, F. (1992). Cocaine use and withdrawal: The effect on sleep and mood. American Journal of Drug and Alcohol Abuse 1821–28.Google Scholar
  76. Weddington, W, Brown, B., Haertzen, C., Cone, E., Dax, E., Herning, R., and Michaelson, B. (1990). Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: A controlled, residential study. Archives of General Psychiatry, 47, 861–868.PubMedCrossRefGoogle Scholar
  77. Weiss, R. D. (1988). Relapse to cocaine abuse after initiating desipramine treatment. Journal of the American Medical Association, 260, 2545–2546.PubMedCrossRefGoogle Scholar
  78. Yagi, B. (1963). Studies in general activity: II. The effect of methamphetamine. Annals of Animal Psychology, 13, 37–47.Google Scholar
  79. Ziedonis, D. M., and Kosten, T. R. (1991a). Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacology Bulletin, 27, 337–343.Google Scholar
  80. Ziedonis, D. M., and Kosten, T. R. (1991b). Pharmacotherapy improves treatment outcome in depressed cocaine addicts. Journal of Psychoactive Drugs, 23, 417–425.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • M. Elena Denison
    • 1
  • Alfonso Paredes
    • 1
  • Shana Bacal
    • 1
  • Frank H. Gawin
    • 1
  1. 1.UCLA-VAMC Laboratory for the Study of AddictionsLos AngelesUSA

Personalised recommendations